Erratum to Dadachova E: Cancer Therapy with Alpha-Emitters Labeled Peptides. Semin Nucl Med 40:204-208, 2010 (DOI:10.1053/j.semnuclmed.2010.01.002);Cancer Therapy with Alpha-Emitters Labeled Peptides

Seminars in Nuclear Medicine

Volumn 40, Issue 3, 2010, Pages 204-208

  Dadachova, Ekaterina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACTINIUM; ACTINIUM 211; ALPHA EMITTER PEPTIDE; ALPHA INTERMEDIN; ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; ASTATINE 211; BISMUTH 212; BISMUTH 213; BOMBESIN DERIVATIVE; GELATIN SUCCINATE; IODINE 131; LEAD 212; LUTETIUM 177; OCTREOTIDE; RADIOISOTOPE; RADIUM 224; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ALPHA RADIATION; ANTINEOPLASTIC ACTIVITY; BLOOD TOXICITY; BRAIN TUMOR; CANCER RADIOTHERAPY; CELL KILLING; CELL SURFACE; DOSE RESPONSE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SYNTHESIS; ELECTRON; HUMAN; IMMUNOGENICITY; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; MELANOMA; NEPHROTOXICITY; NONHUMAN; PANCREAS ADENOCARCINOMA; RADIATION DOSE; REVIEW; TUMOR CELL;

EID: 77949897111     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.04.002     Document Type: Erratum

References (27)

1. Dijkgraaf I., Boerman O.C., Oyen W.J., et al. Development and application of peptide-based radiopharmaceuticals. Anti Cancer Agents Med Chem 7 (2007) 543-551
2. Milenic D.E., Brady E.D., and Brechbiel M.W. Antibody-targeted radiation cancer therapy. Nat Rev Drug Discov 3 (2004) 488-498
3. Humm J.L., and Cobb L.M. Nonuniformity of tumor dose in radioimmunotherapy. J Nucl Med 31 (1990) 75-83
4. Hassfjell S., and Brechbiel M.W. The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications. Chem Rev 101 (2001) 2019-2036
5. Søyland C., and Hassfjell S.P. Survival of human lung epithelial cells following in vitro alpha-particle irradiation with absolute determination of the number of alpha-particle traversals of individual cells. Int J Radiat Biol 76 (2000) 1315-1322
6. Pugliese M., Durante M., Grossi G.F., et al. Inactivation of individual mammalian cells by single alpha-particles. Int J Radiat Biol 72 (1997) 397-407
7. Hei T.K., Wu L., Liu S., et al. Mutagenic effects of a single and an exact number of alpha particles in mammalian cells. Proc Nal Acad Sci U S A 94 (1997) 3765-3770
8. Hall E.J. Radiobiology for the Radiologist. 4th ed. (1994), JB Lippincott Company, Philadelphia, PA
9. Blakely E.A., and Kronenberg A. Heavy-ion radiobiology: New approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat Res 150 (1998) S126-S145
10. Macklis R.M., Lin J.Y., Beresford B., et al. Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: Induction of apoptosis. Radiat Res 130 (1992) 220-226
11. Walicka M.A., Vaidyanathan G., Zalutsky M.R., et al. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211. Radiat Res 150 (1998) 263-268
12. Bishayee A., Rao D.V., Bouchet L.G., et al. Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210. Radiat Res 153 (2000) 416-427
13. Howell R.W., Goddu S.M., Narra V.R., et al. Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: Relative biological effectiveness of alpha-particle emitters in vivo. Radiat Res 147 (1997) 342-348
14. Azure M.T., Archer R.D., Sastry K.S.R., et al. Biological effect of lead-212 localized in the nucleus of mammalian cells: Role of recoil energy in the radiotoxicity of internal alpha-particle emitters. Radiat Res 140 (1994) 276-283
15. Goodhead D.T. Initial events in the cellular effects of ionizing radiations: Clustered damage in DNA. Int J Radiat Biol 65 (1994) 7-17
16. Atcher R.W., Friedman A.M., and Hines J.J. An improved generator for the production of 212Pb and 212Bi from 224Ra. Int J Rad Appl Instrum A 39 (1988) 283-286
17. In: Emran A.M. (Ed). Chemists View of Imaging Centers (1995), Plenum Press, New York, NY
18. Boll R.A., Malkemus D., and Mirzadeh S. Production of actinium-225 for alpha particle mediated radioimmunotherapy. Appl Radiol Isot 62 (2005) 667-679
19. Vaidyanathan G., Boskovitz A., Shankar S., et al. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: Potential peptide radiotherapeutics for somatostatin receptor-positive cancers. Peptides 25 (2004) 2087-2097
20. Vaidyanathan G., Affleck D.J., Schottelius M., et al. Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor. Bioconjug Chem 17 (2006) 195-203
21. Miao Y., Hylarides M., Fisher D.R., et al. Melanoma therapy via peptide-targeted alpha-radiation. Clin Cancer Res 11 (2005) 5616-5621
22. Knör S., Sato S., Huber T., et al. Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer. Eur J Nucl Med Mol Imaging 35 (2008) 53-64
23. Nayak T., Norenberg J., Anderson T., et al. Comparison of high-versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro. Cancer Biother Radiopharm 20 (2005) 52-57
24. Nayak T.K., Norenberg J.P., Anderson T.L., et al. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells. Nucl Med Biol 34 (2007) 185-193
25. 3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model. Clin Cancer Res 12 (2006) 897-903
26. Lindegren S., Andersson H., Jacobsson L., et al. Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: Evaluation for use as an effector molecule in pre-targeted intraperitoneal tumor therapy. Bioconjug Chem 13 (2002) 502-509
27. Kneifel S., Cordier D., Good S., et al. Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance P. Clin Cancer Res 12 (2006) 3843-3850